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Introduction
Epithelial–mesenchymal transition (EMT) is fundamental dur-
ing early development for the reorganization of groups of pro-
genitor cells within a preexisting epithelium into complex sets 
of juxtaposing tissues, thus allowing new inductive patterning 
events necessary for organogenesis. In addition to the formation 
of the three germ layers and the neural crest, EMTs give rise to, 
amongst others, sclerotome from ventral somites; endocardial 
cushions of the atrio-ventricular (A-V) canal of the heart from 
the endocardial epithelium; and bones, cartilage, and muscula-
ture from cells of the neural plate (for review see Savagner, 
2001; Shook and Keller, 2003).
The process of EMT enables epithelial cells, which are 
normally constrained by cell-to-cell adherence, to delaminate 
and take on the invasive and migratory properties that are a fea-
ture of mesenchymal cells. Aberrant reactivation of this process 
in the adult can give rise to undesirable pathological states such 
as tumor progression, whereby delamination of the tumor cells 
and acquisition of invasive and migratory properties is the fore-
bear of metastatic disease (for review see Thiery, 2002). Loss of 
E-cadherin expression facilitates the loss of cell-cell adhesion. 
This is often achieved during EMT by the induction of repressors 
of E-cadherin transcription, such as Snail, ZEB1/δEF1 (Grooteclaes 
and Frisch, 2000), ZEB2/SIP1 (Comijn et al., 2001), E47 (Perez-
Moreno et al., 2001), Twist (Yang et al., 2004), and Slug/Snail2 
(Bolos et al., 2003).
In vivo, the importance of E-cadherin transcriptional re-
pressors in EMT is demonstrated by the role of Snail in EMT. 
Snail-null mice cannot complete gastrulation because they fail 
to down-regulate E-cadherin to undergo EMT (Carver et al., 
2001). Evidence is also accumulating that indicates a role for 
Snail and other transcriptional repressors of E-cadherin in can-
cer progression. In malignant tumors in general, E-cadherin ex-
pression correlates with more highly differentiated cancers that 
exhibit cell–cell adhesion and are less invasive (Thiery, 2002). 
Elevated expression of Snail1, ZEB1, and Twist have been 
found in metastatic cancer cell lines and invasive human can-
cers, with concomitant loss of E-cadherin expression in these 
cell lines and tissues (Peinado et al., 2004; Yang et al., 2004). 
Although these observations clearly illustrate that regulation of 
E-cadherin and its transcriptional repressors are key elements in 
embryonal and pathological EMT, the molecular events that 
initiate the EMT are ill defi  ned.
The TGFβs are pleiotrophic cytokines that regulate cellu-
lar functions ranging from embryonal development to main-
taining homeostasis in the adult. The three mammalian TGFβ 
isoforms (TGFβ1, TGFβ2, and TGFβ3) show high sequence 
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pithelial–mesenchymal transition (EMT), crucial 
during embryogenesis for new tissue and organ 
formation, is also considered to be a prerequisite to 
cancer metastasis. We report here that the protein tyrosine 
phosphatase Pez is expressed transiently in discrete loca-
tions in developing brain, heart, pharyngeal arches, and 
somites in zebraﬁ  sh embryos. We also ﬁ  nd that Pez knock-
down results in defects in these organs, indicating a crucial 
role in organogenesis. Overexpression of Pez in epithelial 
MDCK cells causes EMT, with a drastic change in cell mor-
phology and function that is accompanied by changes in 
gene expression typical of EMT. Transfection of Pez in-
duced TGFβ signaling, critical in developmental EMT with a 
likely role also in oncogenic EMT. In zebraﬁ  sh, TGFβ3 is co-
expressed with Pez in a number of tissues and its expression 
was lost from these tissues when Pez expression was 
knocked down. Together, our data suggest Pez plays a cru-
cial role in organogenesis by inducing TGFβ and EMT.
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homology and have overlapping functions. Most cells, includ-
ing epithelial cells, make TGFβs and express TGFβ receptors 
(Fleisch et al., 2006); hence, the TGFβs can act in a paracrine, 
autocrine, and/or endocrine fashion (Smith, 1996). The role of 
TGFβ in EMT, where it regulates cell–cell adhesion, cytoskele-
tal remodelling, and cell-matrix adhesion, is well documented 
(for review see Zavadil and Bottinger, 2005). In embryonal 
 development,  TGFβ plays a role in organogenesis in the late 
stages of embryogenesis. The requirement for TGFβ in EMT in 
the formation of the endocardial cushions during cardiac valve 
development (Romano and Runyan, 2000) and in EMT involved 
in palate fusion (Kaartinen et al., 1995) support a role for TGFβ 
in EMT in vivo. TGFβ has also been shown to play opposing 
roles in oncogenesis and metastasis (Roberts and Wakefi  eld, 
2003; Siegel et al., 2003). In the early stages of carcinogenesis, 
its epithelial growth suppressive properties liken its role to that 
of a tumor suppressor. However, in tumor cells that have pro-
gressed to evade its anti-proliferative effects, apoptosis and anoikis, 
TGFβ can promote oncogenic EMT leading to an increase in 
invasiveness and motility, the beginnings of metastasis.
Phosphorylation of proteins on tyrosine residues by tyro-
sine kinases and the reversal of the process by protein tyrosine 
phosphatases (PTPs) regulate many diverse cellular functions 
from proliferation to differentiation. The PTP Pez is an intra-
cellular PTP that is located at the adherens junctions (AJ) in 
endothe  lial and epithelial cells (Wadham et al., 2000, 2003). 
Dominant-negative mutants of Pez induce an increase in tyro-
sine phosphorylation at the AJ, which together with the obser-
vation that Pez directly dephosphorylates β-catenin (Wadham 
et al., 2003) suggests that Pez plays a role in regulating the tyro-
sine phosphorylation status of the AJ. However, Pez can be lo-
calized elsewhere in the cytoplasm and in the nucleus (Wadham 
et al., 2000), suggesting that it may have other targets and func-
tions apart from regulating the phosphorylation status of the AJ. 
Here, we show that Pez expression in zebrafi  sh embryos is de-
velopmentally regulated and that knocking down its expression 
results in embryos with defective organ development. In vitro 
and in vivo studies revealed a role for Pez in regulating TGFβ 
and EMT, processes critical for the formation of new tissues and 
organs during embryonic development.
Results
Pez expression is transiently induced 
at speciﬁ  c stages during zebraﬁ  sh 
embryogenesis
The temporal and spatial expression profi  les of a gene in the 
context of a whole organism can shed light on its physiological 
function. To assess whether Pez has a developmental role, we 
examined its temporal and spatial expression profi  les during 
zebrafi  sh embryonal development up to 48 h post-fertilization 
(hpf) by whole-mount in situ hybridization. With the exception 
of maternally derived mRNA present up to 4 hpf (unpublished 
data), Pez expression was not detectable until 16 hpf, at which 
time it became faintly detectable throughout the embryo (un-
published data). Between 22–24 hpf Pez expression was stron-
gest in the ventricular/subventricular zone of the developing 
brain (Fig. 1 A), a region rich in proliferating and migrating 
neuronal progenitors. Pez expression in the brain subsequently 
declined, with very low levels remaining at 36 hpf (Fig. 1 A). 
Pez expression was also detected in the somites at 24 hpf, but 
was no longer detectable by 36 hpf (Fig. 1 B; Fig. S1, available 
at http://www.jcb.org/cgi/content/full/jcb.200705035/DC1), 
suggesting that Pez may play a role in the later stages of somite 
maturation. Transient Pez expression was also observed during 
cardiac development. Pez expression was visible in the early 
developing heart tube at 24 hpf, reaching a peak between 42–44 hpf 
and then rapidly down-regulated, so that by 48 hpf little Pez 
expression remained (Fig. 1 C). Another tissue in which Pez ex-
pression was observed is the pectoral fi  n, where little or no Pez 
expression was detected in the fi  n bud at 36 hpf, but more sus-
tained expression was observed, between 42 to 48 hpf, the latest 
time point investigated. These examples of transient Pez expres-
sion at specifi  c stages of tissue development suggest that Pez 
plays a regulatory role in development.
Pez expression is crucial for organogenesis
To determine whether Pez plays a crucial role in the regulation 
of developmental processes, three different antisense morpholino-
oligonucleotides (MOs) (Fig. 2 A), designed to inhibit trans-
lation of Pez protein, were microinjected into zebrafi  sh embryos 
at the one- to four-cell stage. Embryos injected with a control 
MO were indistinguishable from uninjected controls, whereas 
injection with each of the anti-Pez MOs produced identical 
morphant phenotypes.
Pez morphants displayed a number of defects in sev-
eral organs and tissues (summarized in Table S1, available at 
http://www.jcb.org/cgi/content/full/jcb.200705035/DC1) that 
correlated with regions of Pez expression (see Fig. 1). Most 
  notable was a severe pericardial edema obvious by 2–3 dpf (Fig. 2, 
B and C; Fig. S2). From in situ hybridization (Fig. 1), we had 
noted that Pez expression generally peaks after the rudimentary 
tissues and organs have formed, suggesting that Pez may play a 
role in the development of specifi  c structures within the organs 
rather than in initiating organ development. In concordance 
with this hypothesis, the organs were formed in the Pez mor-
phants, but with architectural defects in multiple organs and 
tissues. Somites and somite boundaries were formed in Pez 
morphants, but the boundaries were irregular (Fig. 2, D and E). 
In the ventricular/subventricular zone of the brain, a region with 
strong Pez expression in wild-type embryos at 24 hpf (Fig. 1 A), 
there was an increase in cellular density and expansion of the 
ventricular zone at the expense of the cortex (Fig. 2, F and G) in 
the Pez morphants compared with uninjected or control MO-
injected embryos. Similarly, structural defects were observed in 
the formation of the pharyngeal arches, which included a higher 
cellular density, shortening, and poor formation of the cartilage 
(Fig. 2, F and G).
The severe pericardial edema observed in Pez morphants 
(Fig. 2, B and C; Fig. S2) is symptomatic of defects in cardiac 
function. To further evaluate cardiac function in Pez morphants, 
we used fl  i1-GFP transgenic zebrafi  sh, which express GFP in the 
endothelial cells comprising the endocardium (Lawson and 
Weinstein, 2002), to visualize structure and function of the NOVEL REGULATOR OF ORGANOGENESIS, TGFβ, AND EMT • WYATT ET AL. 1225
atrium, ventricle, and the atrio-ventricular (A-V) valve in live 
embryos. By 53 hpf, the developing heart of control-injected em-
bryos had begun to loop and the atrium and ventricle were par-
tially superimposed (Fig. 2 H). The A-V valves between the two 
chambers were well developed and opened and shut in syn-
chrony with rhythmic contractions (Fig. 2 H; Video 1, available at 
http://www.jcb.org/cgi/content/full/jcb.200705035/DC1). In con-
trast, the heart of Pez morphants remained tubular, suggesting a 
defect in looping, and they lacked patent A-V valves (Fig. 2 I; 
Video 2), which normally function to prevent regurgitation of 
blood back into the atrium during rhythmic contractions. We also 
observed a loss of unidirectional blood fl  ow in the atrium of Pez 
morphants when the movements of blood cells in the atrium were 
tracked (Fig. 2 J), supporting a lack of functional A-V valve.
Pez-overexpressing MDCK epithelial cells 
undergo EMT
The expression profi  le of Pez during zebrafi  sh development 
indicates that its expression is low or absent until required, 
whereupon it is highly up-regulated in specifi  c tissues and 
contributes to organogenesis. To elucidate the molecular events 
induced by such a marked increase in Pez expression, we over-
expressed Pez in MDCK epithelial cells and selected for clonal 
lines (referred to as Pez-MDCK cells). Pez overexpression 
transformed the normal epithelial morphology of MDCK cells 
into a fibroblast-like morphology (Fig. 3 A), whereas cells 
transfected with the empty expression vector (vector-MDCK) 
remained indistinguishable from parental MDCK cells. The trans-
formation to fi  broblast-like morphology appeared to occur in 
two steps: an initial scattering phenotype (Fig. 3 A, middle) that 
was evident  2–3 wks after transfection and clonal selection 
was followed by a more spindly and elongated morphology 
(Fig. 3 A, right) typical of epithelial cells that have undergone 
EMT. The Pez-MDCK cells appeared to have lost cell–cell 
contact, consistent with loss of junctional E-cadherin visualized 
by indirect immunofl  uorescence (Khew-Goodall and Wadham, 
2005). Total E-cadherin protein expression was examined in 
four representative Pez-MDCK clones and found to be highly 
Figure 1.  Pez expression during zebraﬁ  sh embryogenesis. Zebraﬁ  sh Pez mRNA was detected by whole-mount in situ hybridization. Lateral views of 
embryos at various stages of development are shown; dorsal to the top, anterior to the left. (A) View showing developing brain. Arrow indicates the ventricular/
subventricular zone of the brain in 24-hpf embryo. (B) View of trunk showing Pez expression in somites in 24-hpf embryo. (C) View showing Pez expression 
in the pharyngeal arches (pa) and heart. (D) View showing pectoral ﬁ  n (arrowhead) development. Embryos in B–D were cleared with BBA post-staining.JCB • VOLUME 178 • NUMBER 7 • 2007  1226
down-regulated compared with a pool of vector-MDCK cells 
(Fig. 3 B), suggesting that the loss of junctional E-cadherin was 
not merely due to a translocation of the protein away from the 
cell junctions. Similar results were obtained in a repeat of the 
experiment in which three individual vector-MDCK clones and 
another four representative Pez-MDCK clones were analyzed 
(unpublished data). Analysis of E-cadherin mRNA expression 
in these clones by qRT-PCR indicated that E-cadherin mRNA 
was also markedly down-regulated (Fig. 3 C). Averaging the 
data from four independent Pez-MDCK clones and three vector-
MDCK clones, a >30-fold reduction in E-cadherin mRNA 
was observed in Pez-MDCK clones. The Pez-MDCK clones 
also had markedly up-regulated fi  bronectin (an extracellular 
matrix protein secreted by mesenchymal cells) compared with 
the vector-MDCK clones (Fig. 3 D). In addition, using a Boyden 
chamber assay to measure motility, two representative Pez-MDCK 
clones were found to be highly motile compared with vector-
MDCK cells (Fig. 3 E). The alteration of cellular morphology 
accompanying Pez overexpression in MDCK cells, together 
with the loss of the epithelial marker E-cadherin and gain of 
mesenchymal marker (fi  bronectin) and function (motility), sug-
gests that Pez had induced an EMT.
Pez–MDCK cells express EMT-promoting 
transcription factors
Many studies have shown that the loss of E-cadherin expression 
associated with EMT is a consequence of transcriptional repres-
sion of the E-cadherin gene, particularly by the zinc fi  nger tran-
scriptional repressors such as Snail and Slug (for review see 
Peinado et al., 2004). We compared the mRNA levels of the 
Figure 2.  Phenotype of Pez knock-down zebraﬁ  sh embryos using antisense morpholino oligonucleotides. (A) Schematic showing relative positions of 
Pez antisense morpholino oligonucleotides used for knocking-down Pez expression. B, D, F, and H are control (Co) and C, E, G, and I are Pez morphant 
(Mo) zebraﬁ  sh embryos; B–G embryos are 96 hpf, H–J embryos are 53 hpf. Anterior to the left. (B and C) Lateral view of whole zebraﬁ  sh embryos; pe, 
pericardium. (D and E) Lateral view of trunk showing somite boundaries (short arrow) and pigment (long arrow). (F and G) Longitudinal H&E-stained sec-
tions showing increased cellular density in the developing brain (*), and abnormal formation of pharyngeal arches (pa) in morphant embryos. (H and I) 
Ventro-lateral view. Fluorescence micrographs showing structure of the developing heart of live ﬂ  i-GFP embryos. Schematic below shows relative posi-
tions of atrium (A), ventricle (V), and A-V valve, and arrows indicate direction of normal blood ﬂ  ow. Opening and closing of A-V valve in control and 
lack thereof in Pez morphants can be viewed in Videos 1 and 2, respectively (Videos available at http://www.jcb.org/cgi/content/full/jcb.200705035/DC1). 
(J) Time-lapse light micrographs showing blood ﬂ  ow in atrium of representative MO-injected embryo. Left panels: three sequential frames (12–14) from 
a time-lapse video showing a forward-moving blood cell. Right panels: three sequential frames (22–24) from the same time-lapse video showing 
backward-moving blood cell. Downward arrows track the blood cell in each series and block arrows indicate direction of movement of the indicated 
blood cell.NOVEL REGULATOR OF ORGANOGENESIS, TGFβ, AND EMT • WYATT ET AL. 1227
E-cadherin repressors Snail, Slug, ZEB1, and ZEB2 between 
Pez-MDCK and vector-MDCK cells. Snail and Slug expression 
were elevated in all four Pez-MDCK clones analyzed, averag-
ing  5- and  8-fold higher, respectively, than expression in the 
vector-MDCK clones (Fig. 4, A and B), while ZEB1 and ZEB2 
were induced  9- and  30-fold, respectively (Fig. 4, C and D). 
The marked loss of E-cadherin mRNA along with the induction 
of expression of the E-cadherin repressors Snail, Slug, ZEB1, 
and ZEB2 suggest that the Pez-induced reduction in E-cadherin 
is due to transcriptional repression.
We noted that ZEB1 levels were relatively constant 
  between the Pez-MDCK clones whereas Snail, Slug, and ZEB2 
mRNA levels were highest in clone D, intermediate in clone A, 
and lower in clones G and K (Fig. 4, A, B, and D). Upon further 
passaging, Snail expression in both clones A and D declined to 
the lower levels expressed by clones G and K (unpublished 
data), whereas ZEB1 expression remained relatively unchanged. 
These observations are consistent with the transient nature of 
Snail and ZEB2 expression noted previously (Peinado et al., 
2004), and suggest that at the time of the analysis shown in Fig. 4, 
Figure 3.  Pez overexpression induces an EMT in MDCK cells. (A) A representative clone of vector-MDCK cells (left) or Pez-MDCK cells at 2 wks (middle) or 
several weeks (right) post-transfection. (B) Western blot analysis of E-cadherin expression in a pool of vector-MDCK cells (lane 1) and four representative 
Pez-MDCK clones (lanes 2–5). Actin is shown as a loading control. (B) E-cadherin mRNAs in three representative vector-MDCK (white bars) and four Pez-
MDCK (black bars) clones were measured by quantitative real-time PCR. Relative mRNA units represent mRNA of interest normalized to a GAPDH internal 
control. Error bars represent the SEM of samples assayed in duplicate. Insets show pooled values for the three vector- and four Pez-MDCK clones. P-values 
were derived using the t test, n = 6 for vector-MDCK, n = 8 for Pez-MDCK. (D) Western blot analysis of ﬁ  bronectin expression in three representative vector-
MDCK clones (lanes 1–3) and four representative Pez-MDCK clones (lanes 4–7). α-Tubulin is shown as a loading control. (E) Migratory capacity of one 
representative vector-MDCK clone and two representative Pez-MDCK clones. “% cells migrated” represents the number of cells migrated in a modiﬁ  ed 
Boyden chamber assay, expressed as a percentage of the initial number of plated cells. Error bars represent the SEM of samples assayed in quadruplicate, 
and data are representative of three individual experiments.JCB • VOLUME 178 • NUMBER 7 • 2007  1228
down-regulation of Snail and ZEB2 expression in individual 
Pez-MDCK clones had proceeded to different extents.
Pez induces TGF𝗃 production
TGFβ has previously been shown to induce an EMT in MDCK 
and other epithelial cells through induction of all or a subset 
of the transcription repressors Snail, Slug, ZEB1, and ZEB2 
(Zavadil and Bottinger, 2005), all of which were induced in 
Pez-MDCK cells. We therefore investigated the possibility that 
Pez may be mediating its effects through the action of TGFβ. 
By qRT-PCR, we found that the mRNAs for TGFβ-1, -2, and -3 
were 5, 3, and 15× higher, respectively, in the Pez-MDCK cells 
than in the vector-MDCK cells (Fig. 5 A). To determine whether 
increased TGFβ mRNA expression in the Pez-MDCK cells was 
accompanied by increased secretion of active TGFβ capable of 
inducing an EMT, conditioned medium from the Pez-MDCK 
cells cultured for 72 h was collected and used to culture parental 
MDCK cells. After 1–2 d, parental MDCK cells cultured in Pez-
MDCK–conditioned medium began to lose cell–cell contact and 
scatter, whereas cells cultured in control parental MDCK cell 
conditioned medium remained unaltered (unpublished data). 
After 4–6 d in culture in Pez-MDCK conditioned medium (Fig. 
5 B, Pez CM), the parental MDCK cells underwent a transfor-
mation to a spindly fi  broblast-like morphology resembling that 
of Pez-MDCK cells (Fig. 3 A) and cells treated with rhTGFβ 
(Fig. 5 B, rhTGFβ) that have undergone an EMT. In contrast, 
parental MDCK cells cultured in conditioned medium from 
  parental (Fig. 5 B, parental MDCK CM) or vector-MDCK cells 
(unpublished data) remained epithelial and indistinguishable 
from cells cultured in normal medium (unpublished data). These 
observations suggest that Pez-MDCK conditioned medium con-
tained a soluble factor that was able to promote EMT in a simi-
lar fashion to rhTGFβ, and that this factor was not present at 
levels suffi  cient to induce EMT in conditioned medium obtained 
from parental MDCK or vector-MDCK cells. The transition to a 
mesenchymal morphology induced by Pez-MDCK conditioned 
medium was inhibited by the addition of the inhibitor of TGFβ 
receptor kinase activity, SB-431542, and by a blocking pan-
TGFβ Ab to the Pez-MDCK–conditioned medium, but not by 
an anti-HGF Ab (Fig. 5 B), suggesting that the EMT-promoting 
factor secreted by Pez-MDCK cells was active TGFβ.
Transient Pez overexpression activates 
canonical TGF𝗃 signaling
In Pez-MDCK cell lines, Pez expression has persisted over a 
long period of time, raising the possibility that TGFβ secretion 
and subsequent signaling may be an indirect consequence of Pez 
overexpression. In mammalian cells, ligand binding to the TGFβ 
receptor triggers downstream signaling by phosphorylation of 
the R-Smads, which then complex with the coSmad, Smad4, and 
translocate into the nucleus (for review see Massague and Chen, 
2000). To address the kinetics of Pez-induced TGFβ signaling, 
we initially examined the effect of Pez expression on Smad4 
nuclear translocation in transient transfection assays at 24 h 
post-transfection, when at least 50% of the Pez-transfected cells 
showed elevated Pez expression compared with empty vector-
transfected cells (Fig. 6 A). In control empty vector-transfected 
MDCK cells, Smad4 remained predominantly cytoplasmic 
(Fig. 6 A). In contrast, in MDCK cells transfected with Pez, Smad4 
was translocated into the nucleus (Fig. 6 A), suggesting that 
Pez overexpression induces Smad-dependent TGFβ signaling. 
Addition of a neutralising TGFβ Ab following Pez transfection 
blocked nuclear translocation of Smad4 (Fig. 6 A), confirm-
ing that the nuclear localization of Smad4 was TGFβ specifi  c. 
The ablation of Smad nuclear translocation by the exogenous 
addition of TGFβ Ab also indicates that the activation of TGFβ 
signaling by Pez involves the secretion of active TGFβ.
Examination of Pez expression and TGFβ signaling at 
earlier time points after Pez or vector transfection showed no 
detectable increase in Pez expression in the Pez-transfected cells 
Figure 4.  Effect of Pez overexpression on Snail, Slug, 
ZEB1, and ZEB2 expression. mRNAs from three repre-
sentative vector-MDCK clones (white bars) and four 
representative Pez-MDCK clones (black bars) were 
measured by qRT-PCR. Relative mRNA units represent 
mRNA of interest normalized to a GAPDH internal 
control. Normalizing to other internal controls (β-actin, 
HPRT, and ribosomal RNAs) gave essentially identical 
results to GAPDH. Error bars represent the SEM of 
samples assayed in duplicate. Insets show pooled values 
for the three vector- and four Pez-MDCK clones. P-values 
were derived using the t test, n = 6 for vector-MDCK, 
n = 8 for Pez-MDCK.NOVEL REGULATOR OF ORGANOGENESIS, TGFβ, AND EMT • WYATT ET AL. 1229
compared with vector-transfected cells at 6 h post-transfection, 
but by 12 h post-transfection a small proportion of cells with ele-
vated Pez expression was evident (Fig. 6 B), indicating that ele-
vated Pez expression occurs between 6 to 12 h after transfection. 
Examination of Smad4 subcellular localization at 12 h post-
transfection showed an increase in nuclear Smad in cells with 
elevated Pez expression, suggesting that canonical TGFβ sig-
naling is induced shortly after Pez expression (Fig. 6, C and D). 
The expression of TGFβ mRNAs was also assayed by qRT-PCR 
up to 24 h post-transfection, but no induction was detected 
(unpublished data), suggesting that TGFβ production induced 
by Pez initially occurs by post-transcriptional mechanisms. 
No analyses were performed beyond 24 h post-transfection, as 
Pez expression began to decline after this point (unpublished 
data), making the interpretation of data obtained beyond 24 h 
post-transfection equivocal.
Figure 5.  Pez overexpression induces active TGF𝗃 expression. (A) TGFβ1, -2, and -3 mRNAs were analyzed and presented as described in the legend 
to Fig. 4 B. Parental MDCK cells cultured in Pez-MDCK conditioned medium undergo a TGFβ-dependent transformation to a ﬁ  broblast-like morphology. 
Parental MDCK cells were grown for 6 d in conditioned medium from either normal parental MDCK cells (denoted parental MDCK CM) or Pez-MDCK cells 
(Pez CM). Conditioned media from parental MDCK or Pez-MDCK cells were harvested after 3 d in culture. Where indicated, anti-TGFβ Ab (50 μg/ml), 
anti-HGF Ab (50 μg/ml), or the TGFβ receptor kinase inhibitor SB-431542 (1.0 μM) were added before culture in Pez-MDCK conditioned medium. DMSO 
was used as a vehicle control for SB-431542. Where indicated, rhTGFβ (10 ng/ml) was added to parental cells in normal culture medium. Top panels in 
each set show high magniﬁ  cation and bottom panels show low magniﬁ  cation images. Bars = 0.05 mm.JCB • VOLUME 178 • NUMBER 7 • 2007  1230
Pez regulates TGF𝗃3 expression 
in zebraﬁ  sh embryos
The induction of TGFβ signaling and mRNA synthesis by Pez 
in vitro prompted us to investigate if this is paralleled in vivo. 
Published data on the pattern of TGFβ3 expression (Cheah 
et al., 2005) revealed that its expression closely resembled that 
seen for Pez in zebrafi  sh embryos. We therefore compared the 
profi  les of Pez and TGFβ3 expression during zebrafi  sh develop-
ment and found that they coexpressed in the same subset of cells 
in the ventricular zone of the brain at 24 hpf (Fig. 7, A and B) and 
in the endocardial cells of the heart at 44 hpf (Fig. 7, C and D). 
We also noted that TGFβ3 was expressed in some tissues where 
Pez was not expressed, such as in the lens of the developing eye 
at 24 hpf (Fig. 8 and Fig. 1 A). In addition to the co-temporal 
Figure 6.  Transient Pez overexpression induces Smad4 nuclear translocation. (A) Immunoﬂ  uorescence images of MDCK cells transiently transfected with 
either an empty vector, pCDNA3 (denoted vector), or pCDNA-Pez (denoted Pez), showing Smad4 subcellular localization detected by indirect immuno-
ﬂ  uorescence using a Smad4 mAb (green, top row). The cells were counterstained with DAPI (blue, second row) and a merged image (third row) showing 
nuclear Smad4 in Pez-transfected cells but not cells transfected with empty vector or where the anti-TGFβ Ab was added to the Pez-transfected cells. 
Vector- and Pez-transfected cells were also stained with a Pez Ab to show endogenous Pez expression in vector-transfected and elevated levels of Pez ex-
pression in the Pez-transfected cells (red, bottom row). Cells were processed for immunoﬂ  uorescence 24 h post-transfection. The ﬁ  gure shows one represent-
ative experiment of three separate transfections. Bars = 0.05 mm. (B) Immunoﬂ  uorescence images of MDCK cells at 6 and 12 h post-transfection with 
an empty vector or pCDNA-Pez showing Pez expression detected with an anti-Pez Ab (red). Cells were counterstained with DAPI (blue). Bars = 0.2 mm. 
(C) Immunoﬂ  uorescence images of vector- or Pez-transfected MDCK cells at 12 h post-transfection showing Smad4 (green) localization and Pez (red) expression. 
Cells were counterstained with DAPI. Bars = 0.05 mm. (D) Fluorescence intensity proﬁ  les corresponding to the indicated lines in C showing Smad4 
ﬂ  uorescence intensity (green line) and the corresponding DAPI staining intensity (blue line) to indicate the position of the nuclei. The horizontal broken line 
marks 250 units of ﬂ  uorescence intensity in each panel and scale markings on the Y-axis are at 50 ﬂ  uorescence intensity unit intervals. Fluorescence intensity 
quantitated using Analysis software (Soft-Imaging Systems, Olympus).NOVEL REGULATOR OF ORGANOGENESIS, TGFβ, AND EMT • WYATT ET AL. 1231
expression of Pez and TGFβ3, the high degree of spatial corre-
lation, particularly in the ventricular zone of the brain (Fig. 7 B) 
and in the heart (Fig. 7 D), is highly consistent with the notion 
that in these developing tissues Pez may up-regulate TGFβ3 
expression. To explore this further, we examined the expression 
of TGFβ3 in Pez morphants at 24 hpf. Unlike embryos at later 
stages of development, the morphology and architecture of the 
developing brain and heart tube of the Pez morphants at 24 hpf 
are not overtly different from control MO-injected or wild-type 
embryos. Although morphologically similar at 24 hpf, expres-
sion of TGFβ3 was undetectable in the ventricular zone of the 
brain and the heart tube in the Pez morphants, in contrast to 
control embryos where TGFβ3 was clearly expressed in these 
tissues (Fig. 8). It is also worth noting that in the lens of the de-
veloping eye where Pez is not expressed, TGFβ3 expression 
was unaffected by knocking down Pez expression (Fig. 8).
Discussion
EMT is a process shown to be essential for cell movement to 
facilitate the formation of new tissues and organs during develop-
ment. Collectively, several lines of evidence generated from this 
study indicate that Pez is a novel regulator of TGFβ-mediated 
EMT in vitro and of organogenesis during embryonal develop-
ment. Epithelial MDCK cells overexpressing Pez underwent 
morphological and functional changes, including the acquisi-
tion of cell motility, characteristic of an EMT. The morphologi-
cal and functional changes were accompanied by and are likely 
to be a consequence of changes in gene expression typical of 
EMT, including loss of E-cadherin and up-regulation of the 
EMT-inducing transcription factors, Snail, Slug, ZEB1, and 
ZEB2. The transient nature of Pez expression during zebrafi  sh 
development which correlated with specifi  c stages of organ de-
velopment suggests that Pez plays a role in regulating organo-
genesis. This is further supported by data obtained from zebrafi  sh 
hypomorphic for Pez expression where we observed develop-
mental defects in all organs that expressed Pez during develop-
ment. Given that Pez can promote EMT in vitro, some or all of 
the defects observed in these morphant embryos may be due to 
an inability to induce EMT during organ development.
The role of TGFβ as a driver of developmental EMT is 
well recognized although little is known of the mechanisms that 
initiate TGFβ activation. In these studies we made several obser-
vations suggesting that Pez is a novel inducer of TGFβ signaling. 
In Pez-MDCK cell lines, TGFβ secretion is up-regulated to 
a level capable of promoting EMT. In addition, transient Pez 
overexpression induces TGFβ secretion and canonical Smad-
dependent TGFβ signaling within 6 h of its expression, suggest-
ing that TGFβ signaling is activated as an immediate-early 
response to Pez expression. The early activation of TGFβ by Pez 
was, however, not accompanied by increases in TGFβ mRNAs, 
suggesting that this initial activation occurs by post-transcriptional 
mechanisms which may be due to activation of latent TGFβ 
(for review see Massague and Chen, 2000) or de-repression 
of translation (Fraser et al., 2002). At later stages following 
Pez expression, TGFβ mRNAs were up-regulated as seen in 
Pez-MDCK cell lines that had undergone an EMT. It is well 
documented that TGFβ induces its own transcription (Van 
Obberghen-Schilling et al., 1988; Bascom et al., 1989) and we 
suggest that the initial activation of canonical TGFβ signaling 
by Pez acts to induce subsequent de novo synthesis of TGFβ 
mRNAs by an autoinductive mechanism. This is supported 
by studies in our laboratory showing that exogenous addition of 
rhTGFβ1 to MDCK cells induced TGFβ2 and TGFβ3 mRNAs 
after several days of stimulation (unpublished data). Further-
more, in other studies we have also found that the exogenous 
  addition of rhTGFβ1 to MDCK cells induced the downstream 
effectors of EMT, Snail1 (Fig. S3), ZEB1, and ZEB2 (unpub-
lished data), albeit this also took 3 d or more of continuous stim-
ulation to achieve substantial levels of induction. Together, these 
observations suggest that Pez initially induces TGFβ activation 
by post-transcriptional mechanisms and the resultant activation of 
canonical TGFβ signaling then acts in an autocrine feed-forward 
mechanism to activate subsequent transcription of TGFβs and 
the downstream effectors of EMT. Finally, the high degree of 
correlation between Pez and TGFβ3 expression in the develop-
ing brain and heart of zebrafi  sh embryos and the loss of TGFβ3 
expression in these tissues when Pez was knocked down strongly 
supports our in vitro data that Pez regulates TGFβ production.
In the developing heart, rhythmic contractions signifying 
the beginning of cardiac development are evident at  22 hpf 
and development continues for several days (Beis et al., 2005). 
Although Pez expression was evident at 24 hpf, strong expres-
sion was not observed until 36 hpf (unpublished data), sug-
gesting that it is not essential for the early stages of cardiac 
development, a notion supported by the development of atrium, 
ventricle, and rhythmic contractions in the Pez morphants. 
Instead, strong Pez expression in the heart coincides with loop-
ing of the heart tube and specifi  cation of the AV canal, which 
begin around 36 and 37 hpf, respectively (Yelon and Stainier, 
1999; Walsh and Stainier, 2001). In the early steps of A-V 
valve development, the designated endocardial cells of the 
A-V canal undergo a TGFβ-dependent EMT to form the endo-
cardial cushions, which precede formation of the A-V valves 
(Romano and Runyan, 2000; Armstrong and Bischoff, 2004). 
In zebrafi  sh development, this begins at  45–48 hpf when 
Notch1b expression, which is required in conjunction with 
TGFβ signaling to induce EMT (Timmerman et al., 2004), is 
restricted to the A-V canal (Westin and Lardelli, 1997; Walsh 
and Stainier, 2001). Our studies show that Pez expression per-
sists until  48 hpf and in 44-hpf embryos both Pez and TGFβ3 
colocalize to the endocardium, coinciding precisely with the 
timing of restricted Notch1b expression at the A-V canal and 
the onset of EMT. The defects in cardiac valve development 
and loss of TGFβ3 expression when Pez is knocked down 
strongly suggest that Pez plays a role in initiating TGFβ3-
induced EMT in cardiac valve development. However, TGFβ 
isoforms have also been found to be expressed in newly formed 
mesenchyme as a consequence of EMT (Barnett et al., 1994; 
Camenisch et al., 2002) and that they play subsequent roles in 
further valve development and remodelling. If Pez expression 
results in activation of latent TGFβ, Pez may have a more 
far-reaching role in cardiac valve formation beyond the initial 
induction of EMT.JCB • VOLUME 178 • NUMBER 7 • 2007  1232
Figure 7.  TGF𝗃3 expression correlates with Pez expression in zebraﬁ  sh embryos. (A–C) Whole-mount in situ hybridisations using Pez (left) or TGFβ3 
(right) probes. A, low magniﬁ  cation; B, higher magniﬁ  cation. Lateral views of 24-hpf embryos showing Pez and TGFβ3 colocalization in the ventricular 
zone (arrow) of the brain. (C) Lateral view of 44-hpf embryo showing coexpression of Pez and TGFβ3 in the heart. (D) Longitudinal sections of the embryos 
shown in C through the ventricles (V) (represented by the region marked by the ellipse in C) showing Pez and TGFβ3 staining in the endocardial cells (e) lining 
the cardiac chamber, but not myocardial (m) cells. Anterior to the left. Embryos were BBA cleared post-staining. Bars = 0.05 mm.NOVEL REGULATOR OF ORGANOGENESIS, TGFβ, AND EMT • WYATT ET AL. 1233
Zebrafi   sh embryos hypomorphic for Pez expression 
showed a loss of TGFβ3 expression and increased cellularity in 
the ventricular zone of the developing brain at the expense of 
the cortex, indicative of increased proliferation of the progeni-
tors and/or lack of migration into the cortical region. It is there-
fore of interest to note that TGFβ plays a dual role in neurogenesis 
of the developing cerebral cortex. It encourages the progenitor 
cells of the ventricular zone to exit cell cycle, thereby maintain-
ing an appropriate number of cycling cells (Siegenthaler and 
Miller, 2005), and it promotes migration of the post-mitotic 
cells into the emerging cortex (Siegenthaler and Miller, 2004), 
where they can undergo differentiation into mature neurons. 
The increase in cellular density and expansion of the ventricular 
zone observed in the Pez morphants is therefore consistent with 
a loss of TGFβ3 signaling, leading to an inability of the neuro-
nal precursors to exit cell cycle and migrate out of the prolifera-
tion zone.
Although our in vitro and in vivo data suggest that Pez is 
a crucial regulator of TGFβ signaling, the lack of correlation 
between Pez and TGFβ3 expression in some tissues such as the 
somites suggest that Pez may also mediate its effects by TGFβ-
independent pathways or through TGFβ1- or TGFβ2-mediated 
pathways. Pez expression in the developing somites is restricted 
to the central mesenchymal cell compartment surrounded by 
the epithelium (see Fig. S1) and occurs in a very narrow win-
dow after all the somites have formed and when EMT and re-
epithelialization by mesenchymal–epithelial transition is complete. 
Consistent with the expression profi  le of Pez, somite bound-
aries were formed and maintained in Pez morphants, albeit ragged 
and uneven in appearance. At this stage, it is unclear what the role 
of Pez is in somite development and further work is underway 
to elucidate this.
Finally, loss of E-cadherin accompanied by induction of its 
repressors, Snail, Slug, ZEB1, and ZEB2 in various combinations 
have been observed in a number of epithelial cancer cell lines 
that have undergone an EMT (Batlle et al., 2000; Peinado et al., 
2004). Furthermore, TGFβ signaling is emerging as a dual reg-
ulator of oncogenesis and metastasis (Roberts and Wakefi  eld, 
2003). The data reported here suggests that Pez has the potential 
to play a role in oncogenic EMT. It is therefore of interest to 
note that (Wang et al., 2004) reported a number of somatic mu-
tations in Pez associated with colorectal cancers, although how 
these mutations affect Pez expression or function is unknown. 
Based on our fi  ndings here, we would suggest that the muta-
tions may cause changes either in Pez expression or activity that 
could lead to dysregulation of TGFβ signaling.
Materials and methods
Antibodies and inhibitors
Anti–E-cadherin and anti-ﬁ  bronectin mAbs were from Transduction Labora-
tories, anti-tubulin mAb was from Abcam, goat anti-actin pAb was from 
Santa Cruz Biotechnology, Inc. Anti-TGF-β1,-β2, -β3, and anti-HGF mAbs 
were from R&D systems. The TGFβ receptor kinase inhibitor, SB-431542, 
was obtained from Tocris Bioscience, UK.
Cell culture and transfection
MDCK cells were maintained in DMEM (JRH Biosciences) supplemented 
with 10% fetal bovine serum (JRH Biosciences), or 5% serum for condi-
tioned medium experiments. MDCK cells were transfected with pcDNA3 
eukaryotic expression vector (Invitrogen) or N-terminal Flag-tagged human 
Pez cDNA cloned into pcDNA3 (Wadham et al., 2003) and stable trans-
fectants selected by resistance to 500 μg/ml Geneticin (G418; Promega). 
Single clones of Pez-MDCK cells and either single clones or a pool of vector-
MDCK clones were isolated for analysis.
Western blotting
Cells were lysed in Triton X-100 lysis buffer (50 mM Hepes, pH 7.5, 150 mM 
sodium chloride, 10 mM sodium pyrophosphate, 5 mM EDTA, 50 mM sodium 
ﬂ  uoride, 1 mM sodium orthovanadate, and 1% Triton X-100 with protease 
inhibitor cocktails) and whole-cell lysates analyzed by Western blotting 
with the indicated primary antibodies and appropriate HRP-conjugated 
secondary antibodies detected using enhanced chemiluminescence (ECL 
Plus; GE Healthcare).
Figure 8.  Loss of TGF𝗃3 expression in the 
brain and heart of Pez morphants. Whole-mount 
in situ hybridizations of 24-hpf control (left) or Pez 
morphants (right) showing TGFβ3 expression. 
A, ventral view; B, lateral view. Anterior to the 
left. Embryos were BBA cleared post-staining. 
VZ, ventricular zone. Bars = 0.05 mm.JCB • VOLUME 178 • NUMBER 7 • 2007  1234
Quantitative real-time PCR
Total RNA was extracted from cells using TRIzol reagent (Invitrogen) ac-
cording to the manufacturer’s instructions. 1–2 μg total RNA was primed 
with 10 μM pd(N)6 random hexamer (GE Healthcare) and reverse tran-
scribed using Omniscript reverse transcriptase (QIAGEN) according to the 
manufacturer’s instructions. 2 μl of each 20-μl reverse transcription reac-
tion was used as cDNA template for qRT-PCR, using SYBR Green 2x RT-PCR 
mix (QIAGEN) and 1 μM of each primer. Primer sequences and annealing 
temperatures for primers are shown in Table I. Reactions were performed 
on a Rotor-gene RG-3000 (Corbett Research), with the following cycle 
  parameters: 95°C, 15 min; 94°C, 30 s; 50–65°C, 20 s, 72°C, 20 s × 30–35 
cycles. Melt curves were analyzed from 72–99°C and products run on 2% 
agarose gels to verify homogeneity and correct size of all products.
Migration assay
Migration assays were performed using a modiﬁ  ed Boyden chamber as-
say (Transwells, 6.5-mm diameter, 8-μm pore size; CoStar). 5 × 10
4 cells 
were plated in the upper chamber in serum-free medium (DMEM; JRH Bio-
sciences), and migration toward 10% FBS quantiﬁ  ed 24 h post-plating 
using an MTS/PMS-based assay (CellTiter 96 AQueous Non-Radioactive Cell 
Proliferation Assay; Promega) according to the manufacturer’s instructions. 
Percentage of migrated cells was derived by comparison to a standard 
curve generated using known cell numbers. Standards were assayed in 
duplicate, and MDCK clones in quadruplicate.
Whole-mount in situ hybridizations
Whole-mount in situ hybridization probe templates for zebraﬁ   sh Pez 
(zfPez) and zfTGF-β (zfTGF-β3) were generated by PCR ampliﬁ  cation from 
adult (1 yr) zebraﬁ  sh cDNA, and cloned into pBluescript SK (+) vector 
(Stratagene). For zfPez, a 600-bp region of the zebraﬁ  sh Pez 3′ UTR was 
ampliﬁ  ed using forward primer: 5′-G  T  G  T  C  C  G  C  G  G  T  C  C  A  G  C  A  C  C  T  G    T    C-
A  G  G  A  T  T  T  -3′ and reverse primer: 5′-G  T  G  T  G  A  A  T  T  C  G  A  T  C  A  G  T  C  T  G  G  A  G-
T  T  T  T  T  C  A  G  G  A  -3′, based on EST sequence BQ285767.1. For zfTGF-β3, the 
1.2-kb coding region was ampliﬁ  ed using forward primer: 5′-G  T  G  T  G  A  A  T  -
T  C  A  T  G  C  A  T  T  T  G  G  G  C  A  A  A  G  G  A  C  T  G  -3′ and reverse primer: 5′-G  T  G  T  G  A  A  T  -
T  C  C  C  G  C  G  G  T  C  A  G  C  T  G  C  A  C  T  T  G  C  A  G  G  A  T  T  T  G  -3′, Based on GenBank 
se  quence AY614705.1. DIG-11-UTP–labeled (Roche) sense and antisense 
probes were generated by in vitro transcription (MAXIscript in vitro tran-
scription kit; Ambion) according to the manufacturer’s instructions.
Wild-type zebraﬁ  sh embryos were collected 0–48 hpf, chorions 
  removed, and embryos ﬁ  xed in 4% formaldehyde/PBS for a minimum of 24 h. 
In situ hybridization was performed as described previously (Oxtoby 
and Jowett, 1993) but using 0.2–0.5ng/μl sense or antisense RNA probe 
for hybridization, 1:4,000 dilution of 0.75 U/μl alkaline phosphatase–
conjugated anti-DIG antibody (Roche) at 4°C for 16–18 h for antibody 
binding, and 340 μg/ml 4-nitroblue tetrazolium chloride (NBT)/175μg/ml 
5-bromo-4-chloro-3-indolyl-phosphate toluidine salt (BCIP) stain solution 
(Roche) for signal detection. Where indicated, yolk proteins were cleared 
with benzylbenzoate/benzyl alcohol (2:1) post-staining, as described in 
Schier et al. (1996) before image capture.
Antisense morpholino oligonucleotide injection of zebraﬁ  sh embryos
The human Pez mRNA sequence (GenBank accession no. X82676.1) was 
used to blast the zebraﬁ  sh EST database for homologous sequences. ESTs 
spanning the 5′ (GenBank accession no. AL914296) and 3′ (GenBank 
  accession no. BQ285767.1) ends of the zebraﬁ  sh Pez coding sequence 
were identiﬁ   ed. Forward (5′-T  C  A  T  G  T  G  T  T  T  G  T  C  T  T  G  T  G  G  A  G  -3′) and re-
verse (5′-T  G  C  T  G  G  A  C  A  C  C  G  T  G  T  A  T  C  T  C  -3′) PCR primers were designed to 
amplify a 172-bp region spanning the ATG start site. Based on sequence 
ampliﬁ  ed from adult (1 yr) zebraﬁ  sh cDNA, three independent antisense 
MOs (GeneTools) (PezMO1-3) were designed to block translation by bind-
ing upstream of or spanning the start site. Wild-type or ﬂ  i1-GFP transgenic 
zebraﬁ  sh embryos were collected and injected at one-cell stage with Pez-
speciﬁ  c MO or an irrelevant control using standard procedures. 96-hpf 
embryos were ﬁ  xed in 4% formaldehyde/phosphate-buffered saline (PBS) 
for 16–24 h and either resuspended in 80% glycerol/PBS or embedded in 
parafﬁ  n, and 3-μm sections were cut and stained with hemotoxylin and 
eosin (H&E). For live imaging, embryos were anaesthetised by the addition 
of 0.003% tricaine methanesulfonate to embryo medium and time-lapse 
ﬂ  uorescent images were collected using a microscope (MVX 10; Olympus) 
illuminated with a mercury lamp. MO sequences were as follows: PezMO1 
(nt −40 to −16): 5′-A  G  C  T  T  T  C  C  T  C  T  G  C  G  C  T  T A  A T  C  C  A T  G  -3′; PezMO2 (nt −70 
to −46): 5′-C  G  A  C  C  T  T  C  C  T  C  C  A  A  C  A  G  A  A  C  G  A  T  T  C  -3′; PezMO3 (nt −19 
to +5): 5′-G  G  C  A  T  G  T  T  G  A  A  C  C  C  G  C  G  C  C  G  C  G  A  C  -3′ where +1 is the A of 
the ATG start site. GeneTools standard control MO: 5′-C  C  T  C  T  T  A  C  C  T  C  A  G-
T  T  A  C  A  A  T  T  T  A  T  A  -3′. All zebraﬁ  sh manipulations were performed according 
to guidelines set out and approved by the University of Adelaide Animal 
Ethics Committee.
The MOs were injected at 1, 0.75, and 0.5 mM, with survival rates 
as follows; 1 mM <20%, 0.75 mM  20%, 0.5 mM 70–100%. Surviving 
morphants injected with 0.75-mM MOs had severe defects and were there-
fore not analyzed further. Approximately 80% of morphants derived from 
injecting 0.5 mM MOs had defects of varying degrees and were analyzed 
further. Approximately 100 of each control MO- and Pez MO–injected 
embryos were analyzed.
Image acquisition and analysis
Phase-contrast images were captured using a microscope (IX70; Olympus), 
UPlanFl 10× NA 0.3 Ph1 and LCPlanFl 20× NA 0.4 Ph1 objectives, and 
a camera (DP12; Olympus). Color and ﬂ  uorescent images were captured 
using a microscope (IX81; Olympus) with 10× UPLSApo NA 0.4, 20× 
UPLSApo NA 0.75, and 40× UAPO/340 NA 1.15w objectives and 
CC12 (Soft Imaging System, color) and Hamamatsu Orca-ER (ﬂ  uorescent) 
cameras, respectively. Videos were generated from a microscope (MVX10; 
Olympus) and F-view camera (Soft Imaging System). Fluorescence images 
were acquired using Cell
R software (Olympus Soft Imaging System), all 
other images were acquired and processed using the Analysis software 
(Olympus Soft Imaging System). For immunoﬂ   uorescence images where 
comparisons of staining intensities were made, the images were acquired 
using the same attenuator and exposure settings.
Online supplemental material
Two videos are included displaying cardiac morphology and pumping 
in live control (Video 1) and Pez morphant (Video 2) ﬂ  i-1-GFP  trans-
genic zebraﬁ   sh at 53 hpf. In addition, there are three supplemental 
ﬁ   gures showing a high magniﬁ   cation view of Pez mRNA localization in 
somite of zebraﬁ  sh (Fig. S1), pericardial edema in Pez morphants (Fig. S2), 
and time course of Snail mRNA induction by TGFβ in MDCK cells (Fig. S3), 
and a table summarizing the defects in Pez morphants (Table S1). Online 
supplemental material is available at http://www.jcb.org/cgi/content/
full/jcb.200705035/DC1.
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(Centre for the Molecular Genetics of Development) for advice and help with 
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Table I. qRT-PCR primer sequences and annealing temperatures
Gene Primer sequence Annealing temperature
GAPDH + 5′-C  A  T  C  A  C  T  G  C  C  A  C  C  C  A  G  A  A  G  -3′; −5′-C  A  G  T  G  A  G  C  T  T  C  C  C  G  T  T  C  A  G  -3′ 50–65°C
E-cadherin + 5′-A  A  G  C  G  G  C  C  T  C  T  A  C  A  A  C  T  T  C  A  -3′; −5′-A  A  C  T  G  G  G  A  A  A  T  G  T  G  A  G  C  A  C  C  -3′ 50°C
Snail + 5′-C  C  C  A  A  G  C  C  C  A  G  C  C  G  A  T  G  A  G  -3′; −5′-C  T  T  G  G  C  C  A  C  G  G  A  G  A  G  C  C  C  -3′ 65°C
Slug + 5′-C  G  T  T  T  T  C  C  A  G  A  C  C  C  T  G  G  T  T  A  -3′; −5′-T  G  A  C  C  T  G  T  C  T  G  C  A  A  A  T  G  C  T  C  -3′ 55°C
ZEB1 + 5′-C  A  A  G  G  T  G  G  C  C  A  T  T  C  T  G  T  T  A  T  -3′; −5′-C  T  A  G  G  C  T  G  C  T  C  A  A  G  A  C  T  G  T  A  G  -3′ 55°C
ZEB2 + 5′-C  G  G  T  C  C  A  G  A  A  G  A  A  A  T  G  A  A  G  G  -3′; −5′-T  C  C  T  C  A  A  A  G  T  C  T  G  A  T  G  T  G  C  A  A  -3′ 55°C
TGFβ1 + 5′-T  G  G  A  C  A  C  G  C  A  G  T  A  C  A  G  C  A  A  -3′; −5′-T  A  G  T  A  C  A  C  G  A  T  G  G  G  C  A  G  T  G  G  -3′ 55°C
TGFβ2 + 5′-C  G  T  T  T  A  C  A  G  A  A  C  C  C  G  A  A  A  G  C  -3′; −5′-T  C  G  T  C  T  T  G  A  C  G  A  C  T  T  T  G  C  T  G  -3′ 55°C
TGFβ3 + 5′-C  T  T  G  C  A  C  C  A  C  C  T  T  G  G  A  C  T  T  T  -3′; −5′-C  T  G  T  T  G  T  A  A  A  G  G  G  C  C  A  G  G  A  C  -3′ 55°CNOVEL REGULATOR OF ORGANOGENESIS, TGFβ, AND EMT • WYATT ET AL. 1235
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